-
psnet.ahrq.gov/node/49539/psn-pdf
June 01, 2007 - shared decision making between doctors and patients, allowing
the former to relay information about treatment … , and the latter to decide what can be physically done to
them in the course of treatment.(1)
Although … have sufficient mental capacity to
reach a voluntary decision about whether or not to undergo the treatment … that differs from the original agreement.(8) In this case, the patient received a
treatment to which … The anesthetist giving the treatment is responsible for checking that the patient knows what he or
she
-
psnet.ahrq.gov/node/49426/psn-pdf
November 01, 2003 - She had never
received highly active antiretroviral therapy (HAART). … not described, but, even
when severe, these are not considered justification for IV haloperidol push therapy … Continuous cardiac monitoring during the course of IV
haloperidol push therapy is warranted.(1,2,14) … Neuroleptic treatment of HIV-associated psychosis. HNRC
group. … Psychopharmacological treatment of patients with HIV and AIDS.
-
psnet.ahrq.gov/node/60972/psn-pdf
January 30, 2003 - Unequal Treatment: Confronting Racial and Ethnic
Disparities in Health Care. … https://psnet.ahrq.gov/issue/unequal-treatment-confronting-racial-and-ethnic-disparities-health-care … https://psnet.ahrq.gov/issue/unequal-treatment-confronting-racial-and-ethnic-disparities-health-care
-
psnet.ahrq.gov/node/848090/psn-pdf
April 26, 2023 - Until these cancer drugs are available, many patients will receive no treatment,
or treatment that is … cancer-drug-shortages-are-creating-dire-circumstances-some-patients
https://psnet.ahrq.gov/issue/mounting-drug-shortages-delay-treatments-patients-bladder-cancer
-
psnet.ahrq.gov/perspective/conversation-jose-morfin-md-fasn
April 28, 2021 - With extracorporeal circuits, you are having to do more, even though it's shorter treatments oftentimes … In-center treatments are only three days a week so you have more aggressive fluid removal than if you … After each treatment session, an app will record the treatment, patients can provide comments on the … water and hemodynamics, and then how to adjust the therapy, the limitations of the therapy (for example … Experiences of safety among patients receiving home dialysis therapies.
-
psnet.ahrq.gov/node/864867/psn-pdf
April 10, 2024 - Whether the administration of thrombolytic therapy to a “stroke mimic” equates to a medical
error is … guidelines recommend
thrombolysis to avoid missing the therapeutic window even when a “stroke mimic … While diagnostic uncertainty is not unique to stroke, the time-dependent nature of AIS therapy—amidst … window is narrow, if withholding treatment would cause harm, if the
risk of treatment is acceptably … have
limited access to the patient.2,21
Biases can infiltrate multiple phases of the diagnostic and therapeutic
-
psnet.ahrq.gov/web-mm/hindsight-2020-thrombolytics-alcohol-intoxication
December 18, 2024 - Whether the administration of thrombolytic therapy to a “stroke mimic” equates to a medical error is … guidelines recommend thrombolysis to avoid missing the therapeutic window even when a “stroke mimic” … While diagnostic uncertainty is not unique to stroke, the time-dependent nature of AIS therapy—amidst … window is narrow, if withholding treatment would cause harm, if the risk of treatment is acceptably … have limited access to the patient. 2 , 21 Biases can infiltrate multiple phases of the diagnostic and therapeutic
-
psnet.ahrq.gov/node/837215/psn-pdf
July 08, 2022 - activator) for intravenous thrombolysis in acute ischemic stroke and, more
recently, endovascular therapy … to be at their neurological baseline.1 This extended time window
primarily applies to endovascular therapy … The therapeutic time window for acute ischemic stroke is relatively narrow, and any
delays in diagnosis … window for endovascular treatment. … mechanical thrombectomy, such as
observing for a clinical response after intravenous thrombolytic therapy
-
psnet.ahrq.gov/node/40622/psn-pdf
September 25, 2011 - Alternatives to potentially inappropriate medications for
use in e-prescribing software: triggers and treatment … Alternatives to potentially inappropriate medications for use in e-
prescribing software: triggers and treatment … alternatives-potentially-inappropriate-medications-use-e-prescribing-software-
triggers-and
This study describes the development of improved alerts and alternate treatment
-
psnet.ahrq.gov/node/47432/psn-pdf
September 26, 2018 - Malnutrition in the hospital: the pharmacist’s role in
prevention and treatment. … https://psnet.ahrq.gov/issue/malnutrition-hospital-pharmacists-role-prevention-and-treatment
Parenteral … https://psnet.ahrq.gov/issue/malnutrition-hospital-pharmacists-role-prevention-and-treatment
https://
-
psnet.ahrq.gov/node/50762/psn-pdf
December 18, 2019 - Mounting drug shortages delay treatments for patients
with bladder cancer
December 18, 2019
Tirrell … https://psnet.ahrq.gov/issue/mounting-drug-shortages-delay-treatments-patients-bladder-cancer
Drug shortages … https://psnet.ahrq.gov/issue/mounting-drug-shortages-delay-treatments-patients-bladder-cancer
https:/
-
psnet.ahrq.gov/node/865521/psn-pdf
April 10, 2024 - issue/inappropriate-diagnosis-pneumonia-among-hospitalized-adults
Misdiagnosis may delay appropriate treatment … and/or result in improper treatment.
-
psnet.ahrq.gov/node/847730/psn-pdf
February 26, 2018 - research has documented that implicit bias can compromise clinician decision making regarding
pain treatment … This article summarizes the evidence regarding
gendered norms and gender bias in the treatment of pain … https://psnet.ahrq.gov/issue/woman-who-cried-pain-do-sex-based-disparities-still-exist-experience-and-treatment-pain
-
psnet.ahrq.gov/web-mm/informed-or-misled
April 24, 2018 - shared decision making between doctors and patients, allowing the former to relay information about treatment … , and the latter to decide what can be physically done to them in the course of treatment.( 1 ) Although … that differs from the original agreement.( 8 ) In this case, the patient received a treatment to which … Take-Home Points Consent must be obtained prior to touching a patient or providing treatment and … The anesthetist giving the treatment is responsible for checking that the patient knows what he or she
-
psnet.ahrq.gov/sites/default/files/2024-05/spotlight_case_hindsight_is_2020_slides_final_revised_05.03.2024.pdf
January 01, 2024 - • Whether the administration of thrombolytic therapy to a “stroke mimic” equates to
a medical error … guidelines recommend thrombolysis to avoid missing the
therapeutic window even when a “stroke mimic … Heart Association for Comprehensive Stroke Center certification is
administration of thrombolytic therapy … window is narrow, if withholding treatment would cause
harm, if the risk of treatment is acceptably … .2,21
32
Heuristics and Biases (2)
• Biases can infiltrate multiple phases of the diagnostic and therapeutic
-
psnet.ahrq.gov/node/60610/psn-pdf
June 24, 2020 - due to medical insurance coverage issues and often intolerable
medication side effects from hormonal treatments … When the patient did not improve despite adequate first-line therapy for dysmenorrhea, an opportunity … intervention.22
For this patient, it seems clear that, given the failure of multiple trials of medical therapy … The use of
subsequent hormonal treatment or suppression is of unclear benefit.23 Absent surgical treatment … systemic under-investment in women’s health26 - from education of trainees to
research in effective treatments
-
psnet.ahrq.gov/web-mm/chemotherapy-administration-safety-standards
March 30, 2016 - Inadvertently, while transcribing the order, the pharmacist switched the duration of therapy for the … two agents, entering a single dose of etoposide and 3 days of cisplatin therapy. … The second day of therapy fell on a Saturday, and the satellite pharmacy was closed for the weekend. … , and goals of therapy. … , and goals of therapy.
-
psnet.ahrq.gov/node/840175/psn-pdf
November 16, 2022 - notable
for having had an aortic valve replaced with a titanium valve and chronic management at a therapeutic … the emergency
department (ED), only that she was chronically anticoagulated using warfarin “with a therapeutic … patient with acute mechanical valve thrombosis, with or without arterial thromboembolism, intravenous
therapeutic … Without
administering such a bolus, it may take 12-24 hours to reach a therapeutic heparin level. … Antithrombotic and thrombolytic therapy for valvular disease:
Antithrombotic Therapy and Prevention
-
psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.182_slideshow.ppt
September 01, 2008 - factors for “atypical” causes, such as the patient being an immigrant, closer look is warranted
Specific therapies … The Presented Case
Glucocorticoids not helpful in Strongyloides stercoralis
Proper therapeutic regimen … of RA
Randomized trial compared treatment strategies:
Initial combination therapy with methotrexate … , sulfasalazine, and rapidly tapered high-dose prednisone therapy
Initial combination therapy with methotrexate … disease”
Drug can be stopped if patient does not improve, or if cause for which there are specific therapies
-
psnet.ahrq.gov/web-mm/do-me-favor
September 12, 2016 - found that 99% (n=461) of physicians reported being asked to provide medical advice, diagnosis, or treatment … 3 )
Informal polling of front-line staff at an academic medical center about requests for advice/treatment … considered appropriate, policies should target intimate, invasive, or complex diagnostic work-ups, treatments … prior to making or responding to requests of colleagues for medical treatment. … Self-treatment or treatment of immediate family members. American Medical Association Web site.